CGON
CG Oncology, Inc.
67.40$
+0.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.0% | 97.4% | 99.9% | 99.9% | 99.9% | 99.9% | 96.3% | 95.9% | 95.3% | 95.9% | 97.1% | 96.7% | |
| 4.8% | 4.1% | 13.4% | 4.5% | 7.9% | 34.1% | 5.7% | 2.1% | 6.2% | 4.1% | 3.0% | 1.8% | |
| 96.2% | 94.2% | 97.8% | 98.0% | 97.9% | 98.3% | 94.5% | 94.2% | 93.2% | 93.8% | 94.8% | 94.7% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | |
| – | – | – | – | – | 0.0% | – | – | 0.2% | 0.2% | 0.1% | 0.1% | |
| – | – | – | – | – | 0.0% | – | – | 1.8% | 1.3% | 0.9% | 0.9% | |
| – | – | – | – | – | – | – | – | 0.2% | 0.1% | 0.0% | 0.1% | |
| 5.7% | 7.3% | 1.8% | 2.1% | 2.8% | 2.8% | 3.2% | 4.4% | 5.8% | 4.9% | 3.8% | 5.2% | |
| 5.5% | 7.2% | 1.7% | 2.1% | 2.8% | 2.8% | 3.1% | 4.3% | 4.2% | 3.9% | 3.1% | 4.4% | |
| 0.1% | 0.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | |
| 0.9% | 1.6% | 0.8% | 0.8% | 0.7% | 0.9% | 0.9% | 1.0% | 1.3% | 0.7% | 0.7% | 1.2% | |
| – | – | – | – | – | – | – | – | 0.4% | 0.4% | 0.3% | 0.3% | |
| 94.3% | 92.7% | 98.2% | 97.9% | 97.2% | 97.2% | 96.8% | 95.6% | 94.2% | 95.1% | 96.2% | 94.8% | |
| -53.7% | -65.2% | -25.4% | -29.4% | -33.7% | -28.9% | -34.7% | -41.9% | -46.3% | -47.9% | -38.7% | -47.7% | |
| 31.4% | 33.4% | 11.5% | 11.8% | 12.2% | 8.6% | 10.5% | 10.9% | 10.5% | 9.8% | 7.4% | 8.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.